2
Views
11
CrossRef citations to date
0
Altmetric
Gene Expression

A Lymphoid Cell-Specific Nuclear Factor Containing c-Rel-Like Proteins Preferentially Interacts with Interleukin-6 κΒ-Related Motifs Whose Activities Are Repressed in Lymphoid Cells

, , , , &
Pages 1736-1746 | Received 25 Oct 1991, Accepted 23 Dec 1991, Published online: 31 Mar 2023
 

Abstract

The proto-oncoprotein c-Rel is a member of the nuclear factor κB transcription factor family, which includes the p50 and p65 subunits of nuclear factor κB. We show here that c-Rel binds to κB sites as homodimers as well as heterodimers with p50. These homodimers and heterodimers show distinct DNA-binding specificities and affinities for various κB motifs. In particular, the c-Rel homodimer has a high affinity for interleukin-6 (IL-6) and beta interferon κB sites. In spite of its association with p50 in vitro, however, we found a lymphoid cell-specific nuclear factor in vivo that contains c-Rel but not p50 epitopes; this factor, termed IL-6κB binding factor Π, appears to contain the c-Rel homodimer and preferentially recognizes several IL-6κB-related κB motifs. Although it has been previously shown that the IL-6κB motif functions as a potent IL-1/tumor necrosis factor-responsive element in nonlymphoid cells, its activity was found to be repressed in lymphoid cells such as a Jurkat T-cell line. We also present evidence that IL-6κB binding factor II functions as a repressor specific for IL-6κB-related κB motifs in lymphoid cells.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.